Issued Patents 2025
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12371475 | Nucleic acids encoding anchor modified antibodies and uses thereof | Jason Mastaitis, Andrew J. Murphy, John McWhirter, Vera Voronina | 2025-07-29 |
| 12371503 | Methods of treatment using a leptin receptor agonist antibody | Panayiotis Stevis, Judith Altarejos, Andrew J. Murphy | 2025-07-29 |
| 12359201 | 17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof | Gregory Hinkle, Frederic Tremblay, Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li +6 more | 2025-07-15 |
| 12286677 | Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation | Yurong Xin, Xiping Cheng, Frederick Dewey, Tanya Teslovich Dostal, Claudia Schurmann +2 more | 2025-04-29 |
| 12281173 | Methods for treating patients with hyperlipidemia by administering a PCSK9 inhibitor in combination with an ANGPTL3 inhibitor | Viktoria Gusarova, Andrew J. Murphy | 2025-04-22 |
| 12275792 | Antigen-binding proteins that activate the leptin receptor | Panayiotis Stevis, Judith Altarejos | 2025-04-15 |
| 12209180 | Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists | Viktoria Gusarova, Amy Han, Sokol Haxhinasto, Andrew J. Murphy, William Olson +1 more | 2025-01-28 |